Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

  1. Ailawadhi, S.
  2. Arnulf, B.
  3. Patel, K.
  4. Cavo, M.
  5. Nooka, A.K.
  6. Manier, S.
  7. Callander, N.
  8. Costa, L.J.
  9. Vij, R.
  10. Bahlis, N.J.
  11. Moreau, P.
  12. Solomon, S.
  13. Abrahamsen, I.W.
  14. Baz, R.
  15. Broijl, A.
  16. Chen, C.
  17. Jagannath, S.
  18. Raje, N.
  19. Scheid, C.
  20. Delforge, M.
  21. Benjamin, R.
  22. Pabst, T.
  23. Iida, S.
  24. Berdeja, J.
  25. Giralt, S.
  26. Truppel-Hartmann, A.
  27. Chen, Y.
  28. Zhong, X.
  29. Wu, F.
  30. Piasecki, J.
  31. Eliason, L.
  32. Dhanda, D.
  33. Felten, J.
  34. Caia, A.
  35. Cook, M.
  36. Popa McKiver, M.
  37. Rodríguez-Otero, P.
  38. Show all authors +
Journal:
Blood

ISSN: 1528-0020 0006-4971

Year of publication: 2024

Type: Article

DOI: 10.1182/BLOOD.2024024582 GOOGLE SCHOLAR lock_openOpen access editor